MGI Tech opens Customer Experience Center in Brazil to contribute to the advancement of genomics in Latin America

The laboratory has state-of-the-art technology to support medical research of clinical labs and healthcare institutions, improving precision diagnoses and treatments.  The agricultural sector can also benefit. São Paulo, Brazil – Contributing to the advancement of genomics in Latin America, MGI Tech Co. Ltd. (MGI), a company committed to building core tools and technology to lead life [...]

Launch of high-quality mutant T7 RNA polymerase suitable for mRNA vaccine and therapeutic development

Takara Bio has released PrimeCap T7 RNA Polymerase (low dsRNA) (hereafter referred to as PrimeCap T7 RNA Polymerase), a mutant T7 RNA polymerase suitable for mRNA therapeutic research and development, in March 2024. mRNA vaccines have been deployed effectively as a defense against the coronavirus, with ongoing research extending beyond infectious disease prevention to encompass [...]

AGC Biologics selects Cytiva to provide FlexFactory platforms in new biomanufacturing facility in Japan

New AGC Biologics facility in Yokohama strengthens access to world-class biomanufacturing in Japan, offering mammalian, mRNA and cell therapy services The two FlexFactory manufacturing platforms grow AGC Biologics’ capacity for mRNA, vaccines, and mAbs in Asia Deal marks 150 FlexFactory platforms supplied by Cytiva around the world Cytiva to also provide technology for cell therapy [...]

The New Automated Cell Counter, CytoDirect, Offers Reliable and Stain-free Counting and Viability Measurements

Nänikon, Switzerland – METTLER TOLEDO announces the launch of its new stain-free automated cell counter, CytoDirect. This new product sets a new standard in life sciences by having a smart combination of technologies (digital holographic microscopy and a convolutional neural network) that enables an extra-large measurement area (30x bigger than that of a hemocytometer) and [...]

BioLife Solutions Announces the Divestiture of its Stirling Freezer Business

BOTHELL, Wash. -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") and the broader biopharma markets, today announced that it has completed the divestiture of its wholly owned subsidiary Global Cooling, Inc. ("GCI" or "Stirling"). Roderick de [...]

EditCo Bio, Inc. Unveils Novel Knockout CD4+ T-cell Pools to Transform Cancer and Autoimmune Research

Novel approach to primary T-cell editing through CRISPR-mediated gene engineering offers a scalable, precise solution for laboratories conducting primary immune research REDWOOD CITY, Calif. --EditCo Bio, Inc., a pioneer at the forefront of genome engineering innovation, today announced the launch of its Knockout CD4+ T-cell Pools. This latest addition to EditCo Bio’s product lineup marks [...]

GCI HOLDINGS ACQUIRES STIRLING ULTRACOLD, EXTENDING A LEGACY OF ULTRA-LOW TEMPERATURE STORAGE INNOVATION

Athens, Ohio — Stirling Ultracold, innovative developer and manufacturer of ULT freezers, today announced its business was acquired by GCI Holdings, LLC, an Ohio-based limited liability company. Led by entrepreneur, business consultant, and Stirling’s Director of Operations, Clayton Newman, GCI Holdings has signed a definitive agreement and closed on the acquisition of the ULT storage [...]

New Manufacturing Expansion Parr Instrument Company Announces $22.5 Million Expansion and Renovation Project in Moline, Illinois

Parr Instrument Company has announced plans to build a 54,000 square foot facility adjacent to their existing building at the corner of 53rd Street and 4th Avenue in Moline, Illinois. The new state of the art facility will house the manufacturing operations of the company established in 1899. After completion of the new facility the [...]

TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production

cGMP Facility Streamlines Clinical & Commercial mRNA Drug Substance Development; Built by mRNA & Industry Experts to Meet Demand for mRNA-based Medicine SAN DIEGO -- TriLink BioTechnologies (TriLink®), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has announced the grand opening of its new cGMP mRNA manufacturing facility. [...]

Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadership

SAN DIEGO -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated benchtop DNA and mRNA synthesis solutions, today announced a focus in strategy enabled by the commercial availability of its groundbreaking Gibson SOLA platform. Going forward, the company will increasingly concentrate its efforts on expanding the adoption of Gibson SOLA for both DNA and [...]

Access IBO on Knowledge Center